Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ARIPIPRAZOLE/AE:

Aripiprazole Lauroxil: A Review in Schizophrenia. Frampton JE et al. Drugs. (2017)

Aripiprazole long-acting injectable formulations for schizophrenia: aripiprazole monohydrate and aripiprazole lauroxil. Citrome L et al. Expert Rev Clin Pharmacol. (2016)

Aripiprazole and pregnancy: A retrospective, multicentre study. Galbally M et al. J Affect Disord. (2018)

Search results

Items: 1 to 20 of 225

1.

CYTOTOXIC EFFECTS OF ARIPIPRAZOLE ON MKN45 AND NIH3T3 CELL LINES AND GENOTOXIC EFFECTS ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES.

Shokrzadeh M, Mohammadpour A, Modanloo M, Hassani M, Barghi NG, Niroomand P.

Arq Gastroenterol. 2019 Aug 13;56(2):155-159. doi: 10.1590/S0004-2803.201900000-31.

2.

Safety of aripiprazole for tics in children and adolescents: A systematic review and meta-analysis.

Yang C, Yi Q, Zhang L, Cui H, Mao J.

Medicine (Baltimore). 2019 May;98(22):e15816. doi: 10.1097/MD.0000000000015816.

3.

Drug safety evaluation of aripiprazole in bipolar disorder.

Cuomo A, Beccarini Crescenzi B, Goracci A, Bolognesi S, Giordano N, Rossi R, Facchi E, Neal SM, Fagiolini A.

Expert Opin Drug Saf. 2019 Jun;18(6):455-463. doi: 10.1080/14740338.2019.1617847. Epub 2019 May 17. Review.

PMID:
31072228
4.

Aripiprazole-induced persistent hiccup: a case report and review of the literature.

Serafini G, Piccinini G, Visimberga S, Cervetti A, Belvederi Murri M, Monacelli F, Pompili M, Amore M.

Psychiatr Danub. 2019 Mar;31(1):26-31. doi: 10.24869/psyd.2019.26. Review.

5.

Atypical antipsychotics induce human osteoblasts apoptosis via Wnt/β-catenin signaling.

Li P, Wang Y, Liu X, Zhou Z, Wang J, Zhou H, Zheng L, Yang L.

BMC Pharmacol Toxicol. 2019 Feb 12;20(1):10. doi: 10.1186/s40360-019-0287-9.

6.

Aripiprazole-Induced Hoarseness: A Case Report.

Işik Ü, Çam Ray P.

Clin Neuropharmacol. 2019 Mar/Apr;42(2):55-56. doi: 10.1097/WNF.0000000000000320.

PMID:
30724787
7.

Low-Dose Aripiprazole-Associated Sleepwalking in a Long-Term Zolpidem Treatment Patient With a Depressive Episode: A Case Report.

Chu CW, Liang CS.

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):174-175. doi: 10.1097/JCP.0000000000001001. No abstract available.

PMID:
30624300
8.

A Case of Decreased Milk Production Associated With Aripiprazole.

Yskes R, Thomas R, Nagalla ML.

Prim Care Companion CNS Disord. 2018 Nov 29;20(6). pii: 18l02303. doi: 10.4088/PCC.18l02303. No abstract available.

9.

Hiccups With Dose Titration of Aripiprazole.

Mathews M, Mathews N, Menon N, Ahmad R, Papa-Molter A.

Prim Care Companion CNS Disord. 2018 Nov 22;20(6). pii: 17l02251. doi: 10.4088/PCC.17l02251. No abstract available.

10.

Mortality rate is associated with aripiprazole once-monthly and oral asenapine administration.

Suzuki H, Hibino H, Inoue Y, Takaya A.

Asian J Psychiatr. 2019 Jan;39:22. doi: 10.1016/j.ajp.2018.11.010. Epub 2018 Nov 15. No abstract available.

PMID:
30472350
11.

Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.

Yoshimura B, Sato K, Sakamoto S, Tsukahara M, Yoshimura Y, So R.

Psychopharmacology (Berl). 2019 Feb;236(2):723-730. doi: 10.1007/s00213-018-5101-7. Epub 2018 Nov 15.

PMID:
30443794
12.

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study.

Schöttle D, Janetzky W, Luedecke D, Beck E, Correll CU, Wiedemann K.

BMC Psychiatry. 2018 Nov 14;18(1):365. doi: 10.1186/s12888-018-1946-x. Erratum in: BMC Psychiatry. 2018 Dec 14;18(1):389.

13.

Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.

Dias Alves M, Micoulaud-Franchi JA, Simon N, Vion-Dury J.

J Clin Psychopharmacol. 2018 Dec;38(6):555-562. doi: 10.1097/JCP.0000000000000953.

PMID:
30247179
14.

Hemolytic anemia potentially associated with aripiprazole.

Capeto Coelho I, Aleixo A, Linhares L, Martins A, Telles Correia D.

Psychiatry Clin Neurosci. 2018 Dec;72(12):876. doi: 10.1111/pcn.12781. Epub 2018 Oct 8. No abstract available.

PMID:
30225953
15.
16.

[Hypothermia during Treatment with Aripiprazole].

Kozian R, Schmid G, Demian S.

Psychiatr Prax. 2019 Jan;46(1):49-51. doi: 10.1055/a-0671-6803. Epub 2018 Aug 27. German.

PMID:
30149396
17.

The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study.

Calabrese JR, Sanchez R, Jin N, Amatniek J, Cox K, Johnson B, Perry PP, Hertel P, Such P, McQuade RD, Nyilas M, Carson WH.

J Affect Disord. 2018 Dec 1;241:425-432. doi: 10.1016/j.jad.2018.06.043. Epub 2018 Jul 6.

18.

Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder.

Hebbrecht K, Morrens M, Neels H, Roosens L, Sabbe BGC.

Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):999-1005. doi: 10.1080/17425255.2018.1515911. Epub 2018 Sep 7. Review.

PMID:
30141352
19.

Aripiprazole Lauroxil NanoCrystal® Dispersion Technology (Aristada Initio®).

Ehret MJ, Davis E, Luttrell SE, Clark C.

Clin Schizophr Relat Psychoses. Summer 2018;12(2):92-96. doi: 10.3371/CSRP.EHDA071918.

PMID:
30040476
20.

Aripiprazole-induced atrial fibrillation in a patient with concomitant risk factors.

D'Urso G, Anastasia A, Toscano E, Patti S, de Bartolomeis A.

Exp Clin Psychopharmacol. 2018 Oct;26(5):509-513. doi: 10.1037/pha0000219. Epub 2018 Jul 23.

PMID:
30035575

Supplemental Content

Loading ...
Support Center